论文部分内容阅读
１９９９年１０月２７日Ｇｌａｘｏ Ｗｅｌｌｃｏｍｅ公司宣布：立即从全球市场上撤消其口服喹诺酮类抗生素格帕沙星（ｇｒｅｐａｆｌｏｘａｃｉｎ，商品名Ｒａｘａｒ）。此撤消是公司出于危急性安全考虑而志愿采取的行动。 Ｒａｘａｒ系１９９７年上市的新药，因发现服用Ｒａ
October 27, 1999 Glaxo Wellcome announces immediate withdrawal of its oral quinolone antibiotic grepafloxacin (Raxar) from the global market. This withdrawal is a voluntary action taken by the company for critical safety reasons. Raxar, a new drug marketed in 1997, was found to take Ra